Skip to main content

Table 2 CURB65 Severity for Pneumonia

From: Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii

Score Risk Disposition
0, or 1 1.5% mortality Outpatient care
2 9.2% mortality Inpatient vs observation admission
3 22% mortality Inpatient admission with consideration for ICU admission with score of 4 or 5